Good viruses vs. bad bacteria: new treatment tested for CF lungs
NCT ID NCT07275905
Summary
This early-stage study is testing whether a new treatment called AchromoPhage is safe for adults with cystic fibrosis who have long-term lung infections. AchromoPhage is a mix of four natural viruses designed to find and kill a specific type of bacteria in the lungs. The study will enroll 12 people to try the treatment in different ways—inhaled, given through a vein, or both—to see how their bodies react over six weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS (CF) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of California San Diego (UCSD)
San Diego, California, 92037, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Pittsburgh
Pittsburgh, Pennsylvania, 15213, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.